InsiderTrades

Form 4 for PFE Pfizer

Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-17 · accession 0001225208-21-015184 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-21 2021-12-17 PFE Dolsten Mikael Pres R, D M - OptEx $30.17 +71.2K 351.6K +25% +$2.15M
D 2021-12-21 2021-12-17 PFE Dolsten Mikael Pres R, D I - Discretionary $59.48 -25.2K 46.0K -35% -$1.50M
D 2021-12-21 2021-12-17 PFE Dolsten Mikael Pres R, D M - OptEx $0.00 -152.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-17 M A 71,187 $30.17 351,637 D — — (F1) Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $53.791)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant.
2 Derivative Phantom Stock Units 2021-12-17 I D 25,219 $59.48 45,983 D — · — to — 25,219 Common Stock (F3) The reporting person diversified shares held in the Pfizer Inc. Deferred Compensation Plan (Plan) pursuant to the Plan's diversification provision into an alternate investment option(s) under the Plan. (F2) Each unit represents one phantom share of common stock. (F4) The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
3 Derivative Stock Appreciation Rights 2021-12-17 M D 152,085 $0.00 0 D $30.17 · 2021-02-22 to 2023-02-22 152,085 Common Stock